BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 2, 2004
View Archived Issues
Nastech Gets Approvable Letter For Nascobal Spray
Nastech Pharmaceutical Co. Inc.'s reformulated treatment for vitamin B-12 deficiency, Nascobal (cyanocobalamin) Nasal Spray, received an approvable letter from the FDA. (BioWorld Today)
Read More
MedImmune Starts Enrolling Pivotal Phase III Numax Trial
Read More
Looking Upstream For New Cancer Metastasis Insights
Read More
Hemispherx Gears Up For NDA With Ampligen Data
Read More
Correction
Read More
News From AASLD
Read More
Other News To Note
Read More